Open Access

The bleeding risk the true game changer.

Seminar Presentation

About the speaker

Professor Tobias Geisler

University Hospital of Tuebingen, Tuebingen (Germany)
4 presentations
1 follower

4 more presentations in this session

Welcome & Introduction .

Speaker: Doctor G. Vilahur (Barcelona, ES)


Dual anti platelet therapy duration? Very short or very long?

Speaker: Professor J. ten Berg (Nieuwegein, NL)


De-escalation of monotherapy with P2Y12 inhibitor. An alternative approach.

Speaker: Doctor J. Ferreiro (Hospitalet De Llobregat, ES)


Very low dose of rivaroxaban. It is time for a new era.

Speaker: Professor J. Morais (Leiria, PT)


Access the full session

Welcome and Session 1: From ACS to chronic coronary artery disease. The transition period

Speakers: Professor T. Geisler, Doctor G. Vilahur, Professor J. ten Berg, Doctor J. Ferreiro, Professor J. Morais

About the event


Hot topics and new insights for Thrombosis 2022

17 March 2022 17:00 CET

Related content

ACVC Premium Access

The patient with acute myocarditis.

19 March 2022

ESC Premium Access

Inflammatory targets in atherosclerosis.

27 August 2021

ESC Premium Access

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

27 August 2021

ESC 365 is supported by

logo Novo Nordisk